The Markowetz group develops technologies for doctors to make better decisions faster.
They tackle some of the most deadly cancers with genomes that look like a chaotic mess of missing and redundant parts – like ovarian, oesophageal and pancreatic cancer.
They work on (1) understanding the mechanisms behind this genomic chaos; (2) how to target cancer weaknesses with therapies; (3) how to overcome resistance to treatment; and (4) how to spot cancers as early as possible.
The methods they use combine machine learning and AI with experimental techniques ranging from single cell sequencing to tissue imaging.
